Retina Synthesis

A podcast by Retina Synthesis

Categories:

147 Episodes

  1. Strategies for Treatment Pauses in Neovascular AMD

    Published: 2/2/2023
  2. Gene Therapy of Inherited Retinal Diseases

    Published: 1/26/2023
  3. Suprachoroidal Tyrosinase Therapy of Neovascular AMD

    Published: 1/12/2023
  4. KSI-301 (tarcocimab tedromer) therapy of Retinal Vein Occlusion

    Published: 1/5/2023
  5. The Efficacy of Avacincaptad Pegol in Treatment of Geographic Atrophy: Gather 1 & 2 Study Results

    Published: 12/15/2022
  6. En Face OCT, Intermediate AMD, and Georgraphic Atrophy

    Published: 12/8/2022
  7. Safety of Pegcetacoplan in the 24 month Derby and Oaks Studies

    Published: 12/1/2022
  8. Predominantly Peripheral Lesions on Ultra-Wide field Imaging & Risk of DR Worsening Over Time

    Published: 11/17/2022
  9. 10 Year Retrospective Review of a PHP Device for Early Detection of Neovascular AMD

    Published: 11/10/2022
  10. Current Therapy for Venous Occlusive Disease and a Clinical Trial Involving Stem Cell Therapy for CRVO

    Published: 10/27/2022
  11. Senolytic Therapy for Diabetic Macular Edema and Neovascular AMD

    Published: 10/20/2022
  12. Assessment of Geographic Atrophy Lesion Progression in the Phase 3 Oaks and Derby Trials

    Published: 10/13/2022
  13. The Role of the Clinician in Promoting Innovation

    Published: 10/6/2022
  14. The DAVIO Study: 12 Month Results

    Published: 9/22/2022
  15. Treat and Extend Therapy of Diabetic Macular Edema

    Published: 9/15/2022
  16. Prophylactic IOP Lowering Measures in Anti-VEGF Injections: A Meta-Analysis

    Published: 9/8/2022
  17. Real World Efficacy, Durability and Safety of Faricimab

    Published: 9/1/2022
  18. New Treatments for Radiation Retinopathy

    Published: 8/25/2022
  19. Gene Therapy of Inherited Retinal Diseases

    Published: 8/18/2022
  20. RNA Anti Sense Therapy for Geographic Atrophy

    Published: 8/11/2022

4 / 8

Retina Synthesis is a data-focused resource exploring therapies in development for retinal diseases.